TGFbeta Receptor II Antibodies
- 专利权人:
- 发明人:
- Douglas Bryan Burtrum,Kyla Elizabeth Driscoll
- 申请号：
- US15729818
- 公开号：
- US20180105597A1
- 申请日:
- 2017.10.11
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to antibodies that bind TGFβ receptor II (TGFβRII), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- TGFBETA RECEPTOR II ANTIBODIES
- METHODS OF TREATING CANCER WITH ANTIBODIES THAT TARGET THE INSULIN-LIKE GROWTH FACTOR TYPE I RECEPTOR (IGF-1R)
- Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)
- COMBINED THERAPY
- THERAPEUTIC COMPOSITIONS FOR BOOSTING THE EFFECT OF ANTIBODY THERAPY AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR
